$336.80
-2.26-0.67%
At close: Jul 22, 5:00 PM EST
$336.80
N/A
After Hours: 4:00 PM EST
Krystal Biotech Inc Earnings Estimates
KRYSNASDAQ
Krystal Biotech Earnings Estimates, EPS & Revenue | NASDAQ:KRYS
Krystal Biotech (KRYS) is scheduled to report Q2 earnings on August 3, 2026. Analysts estimate EPS of $1.89 and quarterly revenue of $122.85M.
In the most recent quarter (Q1), Krystal Biotech reported EPS of $1.83, beating estimates of $1.43 by 0.28%. Revenue came in at $116.36M, exceeding the estimate of $112.14M by 0.04%.
Krystal Biotech has beaten EPS estimates in 3 consecutive quarters.
Over the last 4 quarters, Krystal Biotech has averaged an EPS surprise of 0.43% and a revenue surprise of 0.04%.
Earnings Date
Aug 3
EPS Estimate
$1.890
Quarterly Revenue Estimate
$122.85M
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$417.30M
Krystal Biotech Earnings History
Analyze the earnings history of Krystal Biotech using advanced sorting and filters.
Loading calendar...
Krystal Biotech (KRYS) Earnings Per Share
The chart below shows Krystal Biotech's reported EPS compared to analyst estimates over recent quarters.
Krystal Biotech (KRYS) Revenue
The chart below shows Krystal Biotech's reported revenue compared to analyst estimates over recent quarters.
FAQ
When is Krystal Biotech (NASDAQ:KRYS) reporting earnings?
Krystal Biotech (KRYS) is scheduled to report earnings on August 3, 2026. The last reported earnings were for reported on May 4, 2026 for Q1.
What were the latest earnings per share (EPS) for Krystal Biotech (NASDAQ:KRYS)?
The Actual EPS was $1.83, which beat the estimate of $1.43.
What were Krystal Biotech’s (NASDAQ:KRYS) revenues?
The Actual Revenue was $116.36M, which beat the estimate of $112.14M.
